J. Faber

发表

Free thyroxine measured in undiluted serum by dialysis and ultrafiltration: effects of non-thyroidal illness, and an acute load of salicylate or heparin.

J. Faber, I. Waetjen, K. Siersbaek-Nielsen, 1993, Clinica chimica acta; international journal of clinical chemistry.

N‐terminal pro‐B‐type natriuretic peptide in patients with growth hormone disturbances

H. Vestergaard, J. Faber, M. Andreassen, 2007, Clinical endocrinology.

Biomarkers for Mortality and Cardiovascular Events—Reply

P. Hildebrandt, J. Faber, F. Gustafsson, 2005 .

Prevalence of early stages of heart failure in an elderly risk population: the Copenhagen Heart Failure Risk Study

L. Køber, C. Hassager, K. Iversen, 2019, Open Heart.

Increase in thyroglobulin antibody and thyroid peroxidase antibody levels, but not preterm birth-rate, in pregnant Danish women upon iodine fortification.

A. Juul, T. Larsen, L. Hilsted, 2017, European journal of endocrinology.

Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.

L. Hegedüs, B. Nygaard, J. Faber, 1999, Thyroid : official journal of the American Thyroid Association.

Kinetic studies of thyroxine, 3,5,3'-triiodothyronine, 3,3,5'-triiodothyronine, 3',5'-diiodothyronine, 3,3'-diiodothyronine, and 3'-monoiodothyronine in patients with liver cirrhosis.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1981, The Journal of clinical endocrinology and metabolism.

Cardiac function in growth hormone deficient patients before and after 1 year with replacement therapy: a magnetic resonance imaging study

A. Kjær, J. Faber, C. Petersen, 2011, Pituitary.

Biomarkers of endothelial dysfunction are elevated and related to prognosis in chronic heart failure patients with diabetes but not in those without diabetes

G. Lip, P. Hildebrandt, A. Chong, 2008, European journal of heart failure.

Prevalence and characteristics of diabetic patients in a chronic heart failure population.

P. Hildebrandt, S. Galatius, J. Faber, 2005, International journal of cardiology.

Hypoglycemia-Associated EEG Changes Following Antecedent Hypoglycemia in Type 1 Diabetes Mellitus.

Jakob S. Møller, Lise Tarnow, Anne-Sophie Sejling, 2017, Diabetes technology & therapeutics.

Procoagulant State in Current and Former Anabolic Androgenic Steroid Abusers

J. Faber, J. Sidelmann, M. Schou, 2018, Thrombosis and Haemostasis.

Influence of meal composition on postprandial peripheral plasma concentrations of vasoactive peptides in man.

J. Rehfeld, N. Christensen, J. Faber, 1996, Scandinavian journal of clinical and laboratory investigation.

Thyroid dysfunction and electrocardiographic changes in subjects without arrhythmias: a cross-sectional study of primary healthcare subjects from Copenhagen

C. Torp‐Pedersen, J. Nielsen, G. Gislason, 2019, BMJ Open.

Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes.

P. Rossignol, F. Dela, J. Faber, 2019, Diabetes & metabolism.

Atrial natriuretic peptide, copeptin and adrenomedullin levels in polycystic ovary syndrome: a case-control study

J. Faber, S. Skouby, C. Kistorp, 2017, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation

J. Faber, S. Skouby, M. L. Wissing, 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors

G. Laverman, H. Heerspink, R. Gansevoort, 2019, Journal of Clinical Medicine.

Prevalence of heart failure and the diagnostic value of MR‐proANP in outpatients with type 2 diabetes

T. Hansen, M. Jensen, T. Vilsbøll, 2018, Diabetes, obesity & metabolism.

Iodine-Based Contrast Media Cause Hyperthyroidism - Another Important Adverse Reaction to Contrast Media?

H. Thomsen, J. Faber, 2012, Acta radiologica.

EUTHYROID SICK SYNDROME AND FREE THYROXINE ASSAY

J. Faber, K. Siersbaek-Nielsen, R. Ekins, 1983, The Lancet.

Long-Term Outcome in Patients With Heart Failure Treated With Levothyroxine: An Observational Nationwide Cohort Study.

C. Torp-Pedersen, G. Gislason, U. Khalid, 2018, The Journal of clinical endocrinology and metabolism.

Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS

J. Faber, S. Skouby, C. Kistorp, 2017, Endocrine connections.

Associations of Proatrial Natriuretic Peptide with Components of the Metabolic Syndrome in Adolescents and Young Adults from the General Population

J. Jeppesen, L. Andersen, A. Grøntved, 2017, American journal of hypertension.

Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential

J. Faber, S. Skouby, C. Kistorp, 2017, Endocrine connections.

Mid-regional pro-atrial natriuretic peptide and blood pressure in adolescents: Effect of gender and pubertal stage

J. Jeppesen, L. Andersen, A. Grøntved, 2015, Blood pressure.

Myocardial Ischemia Induced by 5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study.

S. Bojesen, T. Klausen, K. Vistisen, 2020, The oncologist.

Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled trial (MIRAD trial)

P. Rossignol, F. Dela, J. Faber, 2019, Diabetes, obesity & metabolism.

Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids

J. Faber, F. Gustafsson, P. Madsen, 2018, American heart journal.

Fatigue, health-related quality-of-life and metabolic changes in men treated with enzalutamide or abiraterone acetate plus prednisone for metastatic castration-resistant prostate cancer: A randomised clinical trial (HEAT).

G. Palapattu, R. Bisbjerg, J. Faber, 2022, European journal of cancer.

Large Discrepancy in the Results of Sensitive Measurements of Thyroglobulin Antibodies in the Follow-Up on Thyroid Cancer: A Diagnostic Dilemma

P. Laurberg, L. Bastholt, A. Handberg, 2012, European Thyroid Journal.

High‐Dose Glucagon Has Hemodynamic Effects Regardless of Cardiac Beta‐Adrenoceptor Blockade: A Randomized Clinical Trial

J. Holst, M. Christensen, F. Knop, 2020, Journal of the American Heart Association.

Metabolic consequences of gonadotropin‐releasing hormone agonists vs orchiectomy: a randomized clinical study

J. Faber, J. Sønksen, F. Bennedbaek, 2018, BJU international.

Short-term teriparatide treatment does not affect NT-proBNP, a marker of cardiac disease

H. Vestergaard, M. Ellegaard, P. Schwarz, 2012, Scandinavian journal of clinical and laboratory investigation.

Mild Thyroid Dysfunction: A Potential Target in Prevention of Atrial Fibrillation?

J. Faber, C. Selmer, 2017, Circulation.

Long-Term Outcome in Levothyroxine Treated Patients With Subclinical Hypothyroidism and Concomitant Heart Disease.

C. Torp-Pedersen, G. Gislason, J. Faber, 2016, The Journal of clinical endocrinology and metabolism.

Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study.

J. Olesen, C. Torp-Pedersen, G. Gislason, 2014, The Journal of clinical endocrinology and metabolism.

Quantification of visceral adipose tissue in polycystic ovary syndrome: dual-energy X-ray absorptiometry versus magnetic resonance imaging

J. Faber, S. Skouby, C. Kistorp, 2018, Acta radiologica.

IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population.

P. Hildebrandt, J. Faber, M. Andreassen, 2009, European journal of endocrinology.

Glucose-Dependent Insulinotropic Polypeptide Augments Glucagon Responses to Hypoglycemia in Type 1 Diabetes

J. Holst, M. Rosenkilde, M. Christensen, 2014, Diabetes.

Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes.

J. Mehlsen, P. Hildebrandt, O. Snorgaard, 1999, Diabetes care.

The influence of free fatty acids on the free fraction of thyroid hormones in serum as estimated by ultrafiltration.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1987, Acta endocrinologica.

The influence of propranolol on the extrathyroidal metabolism of 3,3',5'-triiodothyronine (reverse T3).

J. Faber, K. Siersbaek-Nielsen, T. Friis, 2009, Acta medica Scandinavica. Supplementum.

Complement activation, endothelial dysfunction, insulin resistance and chronic heart failure

G. Lip, P. Hildebrandt, M. Bjerre, 2010, Scandinavian cardiovascular journal : SCJ.

Renal handling of thyroxine, 3,5,3'- and 3,3',5'-triiodothyronine, 3,3'- and 3',5'-diiodothyronine in man.

J. Faber, K. Siersbaek-Nielsen, C. Kirkegaard, 1987, Acta endocrinologica.

GH activity and markers of inflammation: a crossover study in healthy volunteers treated with GH and a GH receptor antagonist.

J. Frystyk, J. Faber, M. Andreassen, 2012, European journal of endocrinology.

Bone Gla protein and sex hormone-binding globulin in nontoxic goiter: parameters for metabolic status at the tissue level.

J. Faber, J. Johansen, H. Perrild, 1990, The Journal of clinical endocrinology and metabolism.

Increased production of thyroxine and inappropriately elevated serum thyrotropin in levels in endogenous depression

A. Korner, J. Faber, C. Kirkegaard, 1990, Biological Psychiatry.

Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.

J. Frystyk, A. Flyvbjerg, J. Faber, 2014, Metabolism: clinical and experimental.

Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status

J. Frystyk, P. Schwarz, J. Faber, 2013, Endocrine.

Very low carbohydrate diet and SGLT-2-inhibitor: double jeopardy in relation to ketoacidosis

E. Eldrup, J. Faber, N. H. Tougaard, 2019, BMJ Case Reports.

Polycystic ovary syndrome and low-grade inflammation with special reference to YKL-40

J. Faber, S. Skouby, M. L. Wissing, 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Pre-meal insulin aspart compared with pre-meal soluble human insulin in type 1 diabetes.

K. Usadel, P. Home, V. Grill, 2006, Diabetes research and clinical practice.

Influence of free thyroid hormone levels on the TSH response to TRH in endogenous depression

J. Faber, C. Kirkegaard, 1986, Psychoneuroendocrinology.

Studies on the influence of biogenic amines and psychoactive drugs on the prognostic value of the TRH stimulation test in endogenous depression

J. Nerup, J. Faber, C. Kirkegaard, 1977, Psychoneuroendocrinology.

Galectin-3 and fibulin-1 in systolic heart failure - relation to glucose metabolism and left ventricular contractile reserve

I. Gustafsson, C. Tuxen, J. Faber, 2017, BMC Cardiovascular Disorders.

The Effect of Empagliflozin on Contractile Reserve in Heart Failure: Prespecified Sub-Study of a Randomized, Double-Blind, and Placebo-Controlled Trial.

L. Køber, C. Tuxen, J. Faber, 2022, American heart journal.

New-Onset Atrial Fibrillation Is a Predictor of Subsequent Hyperthyroidism: A Nationwide Cohort Study

J. Olesen, C. Torp-Pedersen, G. Gislason, 2013, PloS one.

Treatment of subclinical hyperthyroidism: effect on left ventricular mass and function of the heart using magnetic resonance imaging technique

A. Kjaer, J. Faber, C. Petersen, 2015, Endocrine connections.

Subclinical thyroid disease: to treat or not to treat

P. Laurberg, J. Faber, 2001 .

Reference methods for the measurement of free thyroid hormones in blood: evaluation of potential reference methods for free thyroxine.

S. Hansen, P. Staun-Olsen, J. Faber, 2004, Clinical biochemistry.

SERUM LEVELS OF T4, T3, REVERSE T3, 3,3′‐DIIODOTHYRONINE AND 3′,5′‐DIIODOTHYRONINE IN OBESITY, BEFORE AND AFTER JEJUNO‐ILEAL BYPASS

J. Faber, H. Klein, C. Kirkegaard, 1981, Clinical endocrinology.

Treating Hypothyroidism with Thyroxine/Triiodothyronine Combination Therapy in Denmark: Following Guidelines or Following Trends?

B. Nygaard, J. Faber, H. Perrild, 2015, European Thyroid Journal.

Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial.

L. Køber, J. Forman, I. Gustafsson, 2020, The lancet. Diabetes & endocrinology.

Increased blood pressure and aortic stiffness among abusers of anabolic androgenic steroids: potential effect of suppressed natriuretic peptides in plasma?

P. Hovind, J. Faber, F. Gustafsson, 2018, Journal of hypertension.

BETA-BLOCKERS IN THYROTOXICOSIS

J. Faber, T. Friis, C. Kirkegaard, 1980, The Lancet.

Cardiovascular disease and thyroid function.

J. Faber, C. Selmer, 2014, Frontiers of hormone research.

Measurements of serum 3',5'-diiodothyronine and 3,3'-diiodothyronine concentrations in normal subjects and in patients with thyroid and nonthyroid disease: studies of 3',5'-diiodothyronine metabolism.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1979, The Journal of clinical endocrinology and metabolism.

The effect of starvation and refeeding with oral versus intravenous glucose on serum 3,5-,3,3'-and 3'-5'-diiodothyronine and 3'-monoiodothyronine.

J. Faber, S. Jaedig, 1982, Acta endocrinologica.

Familial dysalbuminemic hyperthyroxinemia.

J. Faber, I. W. Jensen, 2009, Acta medica Scandinavica.

Lack of effect of somatostatin on TSH induced T3 release and platelet function in normal man.

J. Nerup, J. Faber, K. Siersbaek-Nielsen, 1977, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Plasma insulin-like growth factor I as predictor of progression and all cause mortality in chronic heart failure.

P. Hildebrandt, J. Faber, F. Gustafsson, 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Mineralocorticoid Receptor Antagonist Improves Cardiac Structure in Type 2 Diabetes: Data From the MIRAD Trial.

J. Forman, P. Rossignol, J. Faber, 2021, JACC. Heart failure.

Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial.

J. Forman, P. Rossignol, J. Faber, 2020, Diabetes & metabolism.

Growth hormone (GH) activity is associated with increased serum oestradiol and reduced Anti‐Müllerian Hormone in healthy male volunteers treated with GH and a GH antagonist

J. Frystyk, A. Juul, J. Faber, 2013, Andrology.

Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial

J. Holst, J. Frystyk, J. Faber, 2018, Diabetes, obesity & metabolism.

Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial.

J. Faber, S. Skouby, C. Kistorp, 2017, Reproductive biomedicine online.

Primary haemostasis in thyroid disease

B. Myrup, J. Faber, C. Bregengård, 1995, Journal of internal medicine.

Pituitary-thyroid axis in critical illness.

H. Westh, J. Faber, C. Kirkegaard, 1987, The Journal of clinical endocrinology and metabolism.

N-terminal-pro-B-type natriuretic peptide in acute hyperthyroidism.

P. Hildebrandt, J. Faber, C. Kistorp, 2007, Thyroid : official journal of the American Thyroid Association.

MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction

T. Hansen, M. Jensen, T. Vilsbøll, 2020, Cardiovascular Diabetology.

Ovarian morphology in polycystic ovary syndrome: estimates from 2D and 3D ultrasound and magnetic resonance imaging and their correlation to anti-Müllerian hormone

J. Faber, S. Skouby, E. Chabanova, 2017, Acta radiologica.

The LIPT-Study: On Risk Markers of Vascular Thrombosis in Polycystic Ovary Syndrome. A Randomized, Double-Blind, Placebo-Controlled Study of the Effect of Liraglutide

J. Faber, S. Skouby, C. Kistorp, 2015 .

The Mineralocorticoid Receptor Antagonist Eplerenone Suppress Interstitial Fibrosis in Subcutaneous Adipose Tissue in Type 2 Diabetes Patients.

F. Jaisser, P. Rossignol, F. Dela, 2020, Diabetes.

Increased levels of TRH in cerebrospinal fluid from patients with endogenous depression

J. Faber, C. Kirkegaard, L. Hummer, 1979, Psychoneuroendocrinology.

The extrathyroidal effect of D,L-propranolol on 3,3',5'-triiodothyronine, 3',5'-diiodothyronine, 3,3'-diiodothyronine, and 3'-monoiodothyronine kinetics.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1982, The Journal of clinical endocrinology and metabolism.

Association of levothyroxine treatment and thyroid peroxidase antibodies with antidepressant use: A Danish population-based longitudinal study.

B. Nygaard, J. Faber, C. Ellervik, 2022, Thyroid : official journal of the American Thyroid Association.

On the role of gallbladder emptying and incretin hormones for nutrient-mediated TSH suppression in patients with type 2 diabetes

J. Holst, T. Vilsbøll, F. Knop, 2014, Endocrine connections.

mediated thyroid-stimulating hormone suppression in patients with type 2

J. Holst, T. Vilsbøll, J. Faber, 2014 .

Acute changes in thyroid volume and function following 131I therapy of multinodular goitre

L. Hegedüs, B. Nygaard, J. Faber, 1994, Clinical endocrinology.

774 Plasma adiponectin, body mass index and mortality in patients with chronic heart failure

J. Frystyk, P. Hildebrandt, S. Galatius, 2005 .

Glucose-Lowering Effects and Low Risk of Hypoglycemia in Patients With Maturity-Onset Diabetes of the Young When Treated With a GLP-1 Receptor Agonist: A Double-Blind, Randomized, Crossover Trial

T. Hansen, O. Pedersen, J. Holst, 2014, Diabetes Care.

Long‐term L‐Triiodothyronine (T3) treatment in stable systolic heart failure patients: a randomised, double‐blind, cross‐over, placebo‐controlled intervention study

B. Nygaard, J. Faber, B. Zerahn, 2015, Clinical endocrinology.

Luteinizing Hormone‐Releasing Hormone Agonists are Superior to Subcapsular Orchiectomy in Lowering Testosterone Levels of Men with Prostate Cancer: Results from a Randomized Clinical Trial

James Henderson, J. Faber, F. N. Bennedbæk, 2017, The Journal of urology.

Characteristics and reference ranges of Insulin-Like Growth Factor-I measured with a commercially available immunoassay in 724 healthy adult Caucasians

J. Faber, M. Andreassen, L. Kristensen, 2009, Scandinavian journal of clinical and laboratory investigation.

Association Between 3-Iodothyronamine (T1AM) Concentrations and Left Ventricular Function in Chronic Heart Failure

J. Köhrle, B. Nygaard, J. Faber, 2018, The Journal of clinical endocrinology and metabolism.

Urinary excretion of free and conjugated 3',5'-diiodothyronine and 3,3'-diiodothyronine.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1981, The Journal of clinical endocrinology and metabolism.

Free thyroxine and 3,3',5'-triiodothyronine levels in cerebrospinal fluid in patients with endogenous depression.

J. Faber, C. Kirkegaard, 1991, Acta endocrinologica.

N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.

P. Hildebrandt, J. Faber, F. Gustafsson, 2005, JAMA.

Peripheral markers of thyroid function: the effect of T4 monotherapy vs T4/T3 combination therapy in hypothyroid subjects in a randomized crossover study

B. Nygaard, J. Kvetny, J. Faber, 2013, Endocrine connections.

N‐terminal‐pro‐B‐type natriuretic peptide (NT‐pro‐BNP) in different thyroid function states

P. Hildebrandt, J. Faber, F. Pedersen, 2004, Clinical endocrinology.

Hemodynamic changes after levothyroxine treatment in subclinical hypothyroidism.

J. Mehlsen, J. Faber, L. Petersen, 2002, Thyroid : official journal of the American Thyroid Association.

Levothyroxine/Liothyronine Combination Therapy and Quality of Life: Is It All about Weight Loss?

B. Nygaard, J. Faber, T. Watt, 2018, European Thyroid Journal.

Thyroid volume and function after 131I treatment of diffuse non‐toxic goitre

B. Nygaard, J. Faber, J. Hansen, 1997, Clinical endocrinology.

Effect of propranolol on extrathyroidal metabolism of thyroxine and 3,3',5-triiodothyronine evaluated by noncompartmental kinetics.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1978, The Journal of clinical endocrinology and metabolism.

The metabolism of iodothyronines in health and disease with special reference to diiodothyronines.

J. Faber, 1984, Danish medical bulletin.

PROPRANOLOL INFLUENCES SERUM T3 AND REVERSE T3 IN HYPERTHYROIDISM

J. Faber, K. Siersbaek-Nielsen, L. Skovsted, 1977, The Lancet.

Cardiovascular Events in Thyroid Disease: A Population Based, Prospective Study

P. Hildebrandt, C. Tuxen, J. Faber, 2011, Hormone and Metabolic Research.

Lack of effects of l-tryptohan on basal and TRH-stimulated TSH and proclatin levels

S. Møller, C. Hagen, J. Faber, 1977, Psychoneuroendocrinology.

Incidence rate of symptomatic painless thyroiditis presenting with thyrotoxicosis in Denmark as evaluated by consecutive thyroid scintigraphies

J. Faber, B. Zerahn, N. Bergmann, 2013, Scandinavian journal of clinical and laboratory investigation.

Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid.

J. Faber, H. Perrild, K. Hørslev-Petersen, 1990, The Journal of clinical endocrinology and metabolism.

Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes

L. Nilas, J. Faber, S. Skouby, 2015, Acta obstetricia et gynecologica Scandinavica.

Effect of combination therapy with thyroxine (T4) and 3,5,3'-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study.

B. Nygaard, J. Kvetny, J. Faber, 2009, European journal of endocrinology.

0-triiodothyronine versus T4 monotherapy in patients with hypothyroidism, a double-blind, randomised cross-over study

B. Nygaard, J. Kvetny, J. Faber, 2009 .

Effect of combination therapy with thyroxine ( T 4 ) and 3 , 5 , 3 0-triiodothyronine versus T 4 monotherapy in patients with hypothyroidism , a double-blind , randomised cross-over study

B. Nygaard, J. Kvetny, J. Faber, 2009 .

Title page Title

J. Faber, M. Andreassen, L. Kristensen, 2008 .

Altered serum levels of thyroxine, triiodothyronines and diiodothyronines in endogenous depression.

J. Faber, C. Kirkegaard, 1981, Acta endocrinologica.

Radioimmunoassay of 3,3',5'-triiodothyronine (reverse T3) on small reusable sephadex columns.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1978, Acta endocrinologica.

Variations in serum T3, rT3, 3,3'-diiodothyronine and 3',5'-diiodothyronine induced by acute myocardial infarction and propranolol.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1980, Acta endocrinologica.

Haemodynamic changes following treatment of subclinical and overt hyperthyroidism.

J. Mehlsen, J. Faber, N. Wiinberg, 2001, European journal of endocrinology.

Scintigraphic evaluation of esophageal transit and gastric emptying in familial dysautonomia.

J. Faber, C. Maayan, Y. Krausz, 1994, European journal of radiology.

Acute hypoglycemia and risk of cardiac arrhythmias in insulin-treated type 2 diabetes and controls

J. Holst, M. Christensen, T. Vilsbøll, 2021, European journal of endocrinology.

Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity

H. Bliddal, R. Christensen, J. Goetze, 2014, BMC Obesity.

Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.

I. Gustafsson, P. Hildebrandt, J. Goetze, 2012, The American journal of cardiology.

α‐Defensins and outcome in patients with chronic heart failure

J. Frystyk, P. Hildebrandt, A. Flyvbjerg, 2012, European journal of heart failure.

Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population.

H. Vestergaard, P. Hildebrandt, J. Faber, 2010, International journal of cardiology.

Changes in bone mass during prolonged subclinical hyperthyroidism due to L-thyroxine treatment: a meta-analysis.

A. Galløe, J. Faber, A. Galløe, 1994, European journal of endocrinology.

The role of thyroid hormones in depression.

J. Faber, C. Kirkegaard, 1998, European journal of endocrinology.

Hyponatremia, all-cause mortality, and risk of cancer diagnoses in the primary care setting: A large population study.

C. Torp-Pedersen, G. Gislason, J. Faber, 2016, European journal of internal medicine.

A simple procedure for routine RNA extraction and miRNA array analyses from a single thyroid in vivo fine needle aspirate

B. Kaczkowski, F. Nielsen, B. Nygaard, 2010, Scandinavian journal of clinical and laboratory investigation.

Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure

Jan Frystyk, Finn Gustafsson, J. Frystyk, 2005, Circulation.

The effects of phenytoin (diphenylhydantoin) on the extrathyroidal turnover of thyroxine, 3,5,3'-triiodothyronine, 3,3',5'-triiodothyronine, and 3',5'-diiodothyronine in man.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1985, The Journal of clinical endocrinology and metabolism.

Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study

A. Juul, J. Faber, F. Gustafsson, 2016, PloS one.

Calcitonin gene‐related peptide in small cell lung carcinomas

J. Faber, S. Schifter, P. Brickell, 1993, Clinical endocrinology.

Appearance of Graves'‐like disease after radioiodine therapy for toxic as well as non‐toxic multinodular goitre

B. Nygaard, J. Faber, J. Hansen, 1995, Clinical Endocrinology.

Hypothyroid Patients Encoding Combined MCT10 and DIO2 Gene Polymorphisms May Prefer L-T3 + L-T4 Combination Treatment – Data Using a Blind, Randomized, Clinical Study

R. Steffensen, P. Laurberg, B. Nygaard, 2017, European Thyroid Journal.

Neither Baseline nor Changes in Serum Triiodothyronine during Levothyroxine/Liothyronine Combination Therapy Predict a Positive Response to This Treatment Modality in Hypothyroid Patients with Persistent Symptoms

B. Nygaard, J. Faber, J. L. la Cour, 2017, European Thyroid Journal.

Levothyroxine Substitution in Patients with Subclinical Hypothyroidism and the Risk of Myocardial Infarction and Mortality

C. Torp-Pedersen, G. Gislason, J. Faber, 2015, PloS one.

Relationships between serum thyrotropin, serum free thyroxine (T4), and 3,5,3'-triiodothyronine (T3) and the daily T4 and T3 production rates in euthyroid patients with multinodular goiter.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1987, The Journal of clinical endocrinology and metabolism.

Intravenous and peroral TRH stimulation in sporadic atoxic goitre.

J. Faber, T. Friis, C. Kirkegaard, 1977, Acta endocrinologica.

Serum T4 T3 and Reverse T3 During Treatment with Propranolol in Hyperthyroidism, L-T4 Treated Myxedema and in Normal Man

J. Faber, K. Siersbaek-Nielsen, L. Skovsted, 1979, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Thyrotropin (TSH) Release During Altered Adrenergic α and β Receptor Influence

J. Nerup, J. Faber, T. Friis, 1976 .

The effect of D,L-4-hydroxypropranolol on the thyroxine to 3,5,3'-triiodothyronine conversion in rat renal and liver microsomes.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1984, Acta endocrinologica.

Effect of occupational exposure to cobalt blue dyes on the thyroid volume and function of female plate painters.

L. Hegedüs, B. Netterstrøm, P. Suadicani, 1992, Scandinavian journal of work, environment & health.

Renal handling of iodothyronines in acromegaly.

P. Eskildsen, J. Faber, K. Siersbaek-Nielsen, 1987, Scandinavian journal of clinical and laboratory investigation.

Urinary excretion of thyroxine, triiodothyronine, 3,3',5'-triiodothyronine (reverse T3) and renal function in human newborns.

J. Faber, K. Siersbaek-Nielsen, C. Kirkegaard, 1978, Acta Endocrinologica.

Simultaneous measurement of 3,5-diiodothyronine and 3,5,3'-triiodothyronine turnover kinetics in euthyroid hyperthyroid, and hypothyroid subjects.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1982, The Journal of clinical endocrinology and metabolism.

A radioimmunoassay of serum 3,5-diiodothyronine.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1981, Acta endocrinologica.

Hepatic extraction and renal production of 3,3'-diiodothyronine and 3',5'-diiodothyronine in man.

J. Wahren, O. Faber, J. Faber, 1980, The Journal of clinical investigation.

Simultaneous turnover studies of thyroxine, 3,5,3' and 3,3',5'-triiodothyronine, 3,5-, 3,3'-, and 3',5'- diiodothyronine, and 3'-monoiodothyronine in chronic renal failure.

J. Heaf, K. Kølendorf, J. Faber, 1983, The Journal of clinical endocrinology and metabolism.

Isolation of radioactive iodothyronines for kinetic studies: a comparison of two methods.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1982, Acta endocrinologica.

Serum free T4, T3, rT3, 3,3'-diiodothyronine and 3',5'-diiodothyronine measured by ultrafiltration.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1984, Acta endocrinologica.

URINARY EXCRETION OF 3,3′,5′‐TRIIODOTHYRONINE (REVERSE T3)

J. Faber, T. Friis, K. Siersbæk-Nielsen, 1978, Clinical endocrinology.

Unrecognized glycometabolic disturbance as measured by hemoglobin A1c is associated with a poor outcome after acute myocardial infarction.

K. Dickstein, I. Gustafsson, P. Hildebrandt, 2007, American heart journal.

Cardiac effects of 3 months treatment of acromegaly evaluated by magnetic resonance imaging and B-type natriuretic peptides

A. Kjær, J. Faber, C. Petersen, 2010, Pituitary.

Combined Type 2 Diabetes and Ischemic Heart Disease: Double Jeopardy

P. Hildebrandt, J. Faber, 2001, Heart Drug.

Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population

H. Vestergaard, P. Hildebrandt, J. Faber, 2010, Inflammation Research.

Endogenous Testosterone Levels Are Associated with Risk of Type 2 Diabetes in Women without Established Comorbidity

C. Torp‐Pedersen, L. Køber, D. Hougaard, 2020, Journal of the Endocrine Society.

The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study

J. Olesen, C. Torp-Pedersen, G. Gislason, 2012, BMJ : British Medical Journal.

Metabolic syndrome and mortality in stable coronary heart disease: relation to gender.

L. Køber, P. Hildebrandt, R. Steffensen, 2007, International journal of cardiology.

Familial Dysalbuminaemic Hyperthyroxinaemia: A Review

J. Faber, I. W. Jensen, 1988, Journal of the Royal Society of Medicine.

Fibroblast growth factor 21 in patients with cardiac cachexia: a possible role of chronic inflammation

J. Faber, C. Kistorp, M. Schou, 2019, ESC heart failure.

The influence of diabetes mellitus on midregional proadrenomedullin concentrations and prognostic value in heart failure outpatients.

I. Gustafsson, T. Klausen, J. Goetze, 2015, Journal of cardiac failure.

Effect of dapagliflozin on cardiac function in people with type 2 diabetes and albuminuria - A double blind randomized placebo-controlled crossover trial.

F. Olsen, M. Jensen, P. Rossing, 2020, Journal of diabetes and its complications.

Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study

L. Køber, C. Hassager, K. Iversen, 2020, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial.

L. Køber, J. Brønd, J. Forman, 2020, American heart journal.

Body mass index in chronic heart failure: association with biomarkers of neurohormonal activation, inflammation and endothelial dysfunction

J. Frystyk, A. Flyvbjerg, J. Goetze, 2013, BMC Cardiovascular Disorders.

N-Terminal Pro-Brain Natriuretic Peptide, C-Reactive Protein, and Urinary Albumin Levels as Predictors of Mortality and Cardiovascular Events in Older Adults

P. Hildebrandt, J. Faber, F. Gustafsson, 2005 .

NT-pro-BNP during hypoglycemia and hypoxemia in normal subjects: impact of renin-angiotensin system activity.

F. Boomsma, B. Thorsteinsson, J. Faber, 2008, Journal of applied physiology.

Gestational age-specific reference ranges from different laboratories misclassify pregnant women's thyroid status: comparison of two longitudinal prospective cohort studies.

A. Juul, T. Larsen, J. Faber, 2014, European journal of endocrinology.

women's thyroid status: comparison of two longitudinal prospective cohort studies"

A. Juul, T. Larsen, J. Faber, 2013 .

Early Stages of Obesity-related Heart Failure Are Associated with Natriuretic Peptide Deficiency and an Overall Lack of Neurohormonal Activation: The Copenhagen Heart Failure Risk Study

L. Køber, C. Hassager, K. Iversen, 2020, Global heart.

The impact of the glucagon‐like peptide‐1 receptor agonist liraglutide on natriuretic peptides in heart failure patients with reduced ejection fraction with and without type 2 diabetes

L. Tarnow, I. Gustafsson, A. Flyvbjerg, 2020, Diabetes, obesity & metabolism.

The effect of liraglutide on renal function: A randomized clinical trial

T. Hansen, P. Rossing, F. Persson, 2017, Diabetes, obesity & metabolism.

Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)

A. Kjær, P. Rossing, S. Inzucchi, 2019, BMJ Open.

Plasma YKL-40 levels are elevated in patients with chronic heart failure

G. Lip, H. Vestergaard, P. Hildebrandt, 2010, Scandinavian cardiovascular journal : SCJ.

Long-term stability of thyroid peroxidase antibody (anti-TPO) in serum in the Danish General Suburban Population Study

B. Nygaard, J. Faber, C. Ellervik, 2023, Clinical Chemistry and Laboratory Medicine.

Patient preferences for diabetes management among people with type 2 diabetes in Denmark – a discrete choice experiment

T. Vilsbøll, J. Henriksen, J. Faber, 2011, Current medical research and opinion.

The use of exercise interventions to overcome adverse effects of androgen deprivation therapy

J. Faber, F. N. Bennedbæk, J. Sønksen, 2016, Nature Reviews Urology.

Familial Non-Toxic Hyperthyroxinaemia: Receptor or 5′-Deiodinase Defect or Deficiency

J. Faber, T. C. Harvey, D. Crothers, 1992, Annals of clinical biochemistry.

Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub‐analysis of a randomized, placebo‐controlled, double‐blind, crossover trial

T. Hansen, P. Rossing, F. Persson, 2017, Diabetes, obesity & metabolism.

Influence of adsorption and deproteination on potential free thyroxine reference methods.

S. Hansen, P. Staun-Olsen, J. Faber, 2002, Clinical chemistry.

Euthyroid hyperthyroxinemia due to a generalized 5'-deiodinase defect.

L. Kahana, M. Scheinfeld, J. Faber, 1988, The Journal of clinical endocrinology and metabolism.

The bioavailability of thyroxine and 3,5,3'-triiodothyronine in normal subjects and in hyper- and hypothyroid patients.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1985, Acta endocrinologica.

Familial progressive neuronal disease and chronic idiopathic intestinal pseudo‐obstruction

A. Gilai, J. Faber, A. Fich, 1987, Neurology.

METABOLIC CLEARANCE AND PRODUCTION RATES OF 3,3′‐DIIODOTHYRONINE, 3′,5′‐DIIODOTHYRONINE AND 3′‐MONOIODOTHYRONINE IN HYPER‐ AND HYPOTHYROIDISM

J. Faber, T. Friis, C. Kirkegaard, 1982, Clinical endocrinology.

Serum 3'-monoiodothyronine levels in normal subjects and in patients with thyroid and non-thyroid disease.

K. Kølendorf, J. Faber, K. Siersbaek-Nielsen, 1981, Acta endocrinologica.

Hypothyroidism and its influence in the development of Metabolic Syndrome (MetS)

J. Faber, M. Němeček, P. Cortez, 2021, medRxiv.

Influence of Erythropoietin on Cognitive Performance during Experimental Hypoglycemia in Patients with Type 1 Diabetes Mellitus: A Randomized Cross-Over Trial

J. Holst, L. Tarnow, F. Dela, 2013, PloS one.

Insulin sensitivity in relation to fat distribution and plasma adipocytokines among abusers of anabolic androgenic steroids

F. Dela, J. Frystyk, J. Faber, 2017, Clinical endocrinology.

Serum Bone Gla Protein (BGP) During Treatment of Hyperthyroidism and Hypothyroidism

J. Faber, J. Johansen, H. Perrild, 1991, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Improved sensitivity of serum thyrotropin measurements. Studies on serum sex hormone-binding globulin in patients with reduced serum thyrotropin.

A. Gam, J. Faber, K. Siersbaek-Nielsen, 1990, Acta Endocrinologica.

Immunoradiometric assay of serum thyroid stimulating hormone (TSH) as a first-line test in a mixed hospital population.

J. Faber, D. Rønnov‐Jessen, L. Skov, 1987, Clinica chimica acta; international journal of clinical chemistry.

Subtle changes in serum thyrotrophin (TSH) and sex‐hormone‐binding globulin (SHBG) levels during long‐term follow‐up after radioactive iodine in multinodular non‐toxic goitre.

L. Hegedüs, J. Faber, J. Hansen, 1992, Clinical endocrinology.

Familial intestinal pseudoobstruction dominated by a progressive neurologic disease at a young age.

A. Gilai, J. Faber, S. Freier, 1987, Gastroenterology.

The extrathyroidal conversion of 3,5,3'-triiodothyronine to 3,5-diiodothyronine in patients with liver cirrhosis.

J. Faber, K. Siersbaek-Nielsen, T. Friis, 1983, The Journal of clinical endocrinology and metabolism.

131I treatment of nodular non-toxic goitre.

L. Hegedüs, B. Nygaard, J. Faber, 1996, European journal of endocrinology.

Infrared thermographic assessment of changes in skin temperature during hypoglycaemia in patients with type 1 diabetes

Lise Tarnow, Anne-Sophie Sejling, Troels W. Kjaer, 2015, Diabetologia.

Hypoglycemia-Associated Changes in the Electroencephalogram in Patients With Type 1 Diabetes and Normal Hypoglycemia Awareness or Unawareness

Troels W. Kjær, Lise Tarnow, Anne-Sophie Sejling, 2014, Diabetes.

Editorial commentary: Subclinical thyroid dysfunction and cardiovascular risk: Nothing to lose, everything to gain?

J. Faber, C. Selmer, 2020, Trends in cardiovascular medicine.

The effect of liraglutide on renal function: A randomised clinical trial

T. Hansen, P. Rossing, F. Persson, 2016 .

Serum free 3,5,3'-triiodothyronine (T3) in non-thyroidal somatic illness, as measured by ultrafiltration and immunoextraction.

J. Faber, K. Siersbæk-Nielsen, 1996, Clinica chimica acta; international journal of clinical chemistry.

Glucose-Lowering Effects and Low Risk of Hypoglycemia in Patients With Maturity-Onset Diabetes of the Young When Treated With a GLP-1 Receptor Agonist: A Double-Blind, Randomized, Crossover Trial

O. Pedersen, J. Holst, T. Vilsbøll, 2014, Diabetes Care.

Treating Hypothyroidism with Thyroxine/Triiodothyronine Combination Therapy in Denmark: Following Guidelines or Following Trends?

B. Nygaard, J. Faber, H. Perrild, 2015, European Thyroid Journal.